News Vertex Pharma makes progress in quest for non-opioid pain dr... The search for an alternative to opioid drugs for pain relief has dragged one for decades, with little success, but Vertex Pharma thinks that could be about to change. The company
News Teva will appeal opioid liability ruling in New York trial The jury in a new York trial has found that Teva Pharmaceuticals played a role in fuelling the opioid crisis in the US, and should
Partner Content Partner Content Top-Level industry professionals to speak at Pain Therapeuti... 2 weeks Pain Therapeutics Conference - expert speakers
Partner Content Partner Content Due to COVID-19, Pain Therapeutics Conference, May 2020 will... COVID-19 means Pain Therapeutics Conference is Remote
Partner Content Partner Content Chair invite Kerrie Brady & Michael Scherz released ahead of... Invite from Chairs Pain Therapeutics
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.